357BLB(1) In section 357BLA, the companyʼs “qualifying expenditure on relevant R&D undertaken in-house” means the expenditure incurred by the company during the relevant period which meets conditions A and B.
357BLB(2) Condition A is that the expenditure is–
(a)incurred on staffing costs,
(b)incurred on software or consumable items,
(c)qualifying expenditure on externally provided workers, or
(d)incurred on relevant payments to the subjects of clinical trials.
357BLB(3) Condition B is that the expenditure is attributable to relevant research and development undertaken by the company itself.